Co-founder and Chief Scientific Officer
Antheia, Inc.
Kristy has nearly 20 years of experience in the field of synthetic biology focusing on yeast metabolic engineering for the production of small molecules. She did the founding work on the benzylisoquinoline alkaloid pathway while earning a Ph.D. in chemical engineering at Caltech and gained valuable industry experience at both Amyris and Lygos. She is currently a co-founder and CSO at Antheia developing yeast strains to produce plant-inspired medicines. Kristy is an expert in tool development, HTP screening, and host strain and heterologous pathway engineering.